‘India can be an innovator as well as a leader in generics’
Dr Swati Piramal, Vice Chairperson, Piramal Enterprises stresses on the need for new government policies in an interaction with…
Author
On the ‘red list’ in Vietnam?
Why are pharma companies in India still falling foul of overseas regulators?